Aerovate Therapeutics Inc
NASDAQ:JBIO

Watchlist Manager
Aerovate Therapeutics Inc Logo
Aerovate Therapeutics Inc
NASDAQ:JBIO
Watchlist
Price: 9.51 USD 7.95% Market Closed
Market Cap: 306.6m USD

Dividends

Dividend Yield
Lowest
Average
Highest
Dividend Per Share
Growth 3Y
Growth 5Y
Growth 10Y
Dividend Safety Score
Very
Unsafe
Unsafe
Safe
Very
Safe
0
25
50
75
100
Previous Payment
-
Today
Next Payment
-
Today
Jul 18, 2025
Previous Payment
-
Next Payment
-
Ex-Dividend Date
-

Dividend Yield
Aerovate Therapeutics Inc

Period
3Y
5Y
10Y
15Y
30Y
Yield Statistics, Past 5 Years
Min
Max
Current Yield
Min Yield
Max Yield
Average Yield
Median Yield

Dividend Per Share
Aerovate Therapeutics Inc

Over the past 5 years, dividends per share for JBIO have decreased by 0%.
What is dividend per share?
Dividend Streak
Growth 3Y
Growth 5Y
Growth 10Y
Ex-Dividend Date Amount Period Declaration Date Record Date Payment Date
Load More

Payout Ratio
Aerovate Therapeutics Inc

Period
3Y
5Y
10Y
15Y
30Y
Payout Statistics, Past 5 Years
Min
Max
Current Payout
Min Payout Unlock
Max Payout Unlock
Average Payout Unlock
Median Payout Unlock

Peers Comparison
Dividends

Company Safety Rate Dividend Yield Dividend Per Share Growth 5Y Growth 10Y Payout Ratio

Shareholder Yield

Current shareholder yield for JBIO is hidden .

Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?

Shareholder Yield
HIDDEN
Show
Dividend Yield
Lowest
Average
Highest
Buyback Yield
HIDDEN
Debt Paydown Yield
HIDDEN

Peers Comparison
Shareholder Yield

Company Total Yield Dividend Yield Buyback Yield Debt Paydown Yield

Buybacks

Buyback Yield measures how much a company reduces its outstanding shares through repurchases, expressed as a percentage.

This metric directly reflects the company’s efforts to return value to shareholders. By reducing the number of shares, buybacks can increase earnings per share and potentially boost the stock's price.

Unlock Buyback Yield

Peers Comparison
Buybacks

Company Buyback Yield Average Yield (3Y) Average Yield (5Y) Average Yield (10Y)

Debt Paydown

Debt Paydown Yield measures the amount of debt a company repays within a specific period, shown as a percentage of its market capitalization.

This metric indicates how the company is using its capital to decrease financial liabilities, which can strengthen its financial health and potentially enhance shareholder value.

Unlock Debt Paydown Yield

Peers Comparison
Debt Paydown

Company Debt Paydown Yield Average Yield (3Y) Average Yield (5Y) Average Yield (10Y)

Price Appreciation

AVTE Price
Aerovate Therapeutics Inc

1M 1M
-
6M 6M
+5%
1Y 1Y
+47%
3Y 3Y
-83%
5Y 5Y
-88%
10Y 10Y
-88%
Annual Price Range
2.68
52w Low
55.9313
52w High
95.1515
Price Metrics
Average Annual Return 25.29%
Standard Deviation of Annual Returns 106.93%
Max Drawdown -95%
Shares Statistics
Market Capitalization 75.7m USD
Shares Outstanding 828 143
Percentage of Shares Shorted 1.15%

AVTE Return Decomposition
Main factors of price return

What is price return decomposition?

Stock Splits

JBIO's latest stock split occurred on Apr 29, 2025

The company executed a 1-for-35 stock split, meaning that for every 35 shares held, investors received 1 new share.

Before the split, JBIO traded at 2.68 per share. Afterward, the share price was about 10.14.

The adjusted shares began trading on Apr 29, 2025. This was the only stock split in JBIO's history.

Pre-Split Price
91.4 2.68
Post-Split Price
10.14
Before
After